02393.HK
Yestar Healthcare Holdings Company Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 0.06
−1.56%Year over year
Reported trailing growth
- Revenue
- -30.4%
- EBITDA
- +163.6%
- EBIT
- +102.5%
- EPS
- +48.1%
- Free cash flow
- -64.5%
- Operating cash flow
- -46.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -19.0%
- EBITDA
- +38.1%
- EBIT
- -92.7%
- Net income
- —
- EPS
- —
- Free cash flow
- -0.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026